FI114011B - Suonensisäiseen käyttöön tarkoitetun immunoglobuliinin käyttö farmaseuttisen koostumuksen valmistamiseksi syöpäsairauksien hoitamiseksi - Google Patents

Suonensisäiseen käyttöön tarkoitetun immunoglobuliinin käyttö farmaseuttisen koostumuksen valmistamiseksi syöpäsairauksien hoitamiseksi Download PDF

Info

Publication number
FI114011B
FI114011B FI963598A FI963598A FI114011B FI 114011 B FI114011 B FI 114011B FI 963598 A FI963598 A FI 963598A FI 963598 A FI963598 A FI 963598A FI 114011 B FI114011 B FI 114011B
Authority
FI
Finland
Prior art keywords
ivig
mice
tumor
preparation
intravenous
Prior art date
Application number
FI963598A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963598A (fi
FI963598A0 (fi
Inventor
Pnina Fishman
Yehuda Shoenfeld
Original Assignee
Arp Biomed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26907064&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI114011(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Arp Biomed Ltd filed Critical Arp Biomed Ltd
Publication of FI963598A publication Critical patent/FI963598A/fi
Publication of FI963598A0 publication Critical patent/FI963598A0/fi
Application granted granted Critical
Publication of FI114011B publication Critical patent/FI114011B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/54—F(ab')2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI963598A 1994-03-14 1996-09-12 Suonensisäiseen käyttöön tarkoitetun immunoglobuliinin käyttö farmaseuttisen koostumuksen valmistamiseksi syöpäsairauksien hoitamiseksi FI114011B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US21236194A 1994-03-14 1994-03-14
US21236194 1994-03-14
US08/340,094 US5562902A (en) 1994-03-14 1994-11-15 Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin
US34009494 1994-11-15
PCT/US1995/002910 WO1995024927A1 (en) 1994-03-14 1995-03-09 Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins
US9502910 1995-03-09

Publications (3)

Publication Number Publication Date
FI963598A FI963598A (fi) 1996-09-12
FI963598A0 FI963598A0 (fi) 1996-09-12
FI114011B true FI114011B (fi) 2004-07-30

Family

ID=26907064

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963598A FI114011B (fi) 1994-03-14 1996-09-12 Suonensisäiseen käyttöön tarkoitetun immunoglobuliinin käyttö farmaseuttisen koostumuksen valmistamiseksi syöpäsairauksien hoitamiseksi

Country Status (20)

Country Link
US (2) US5562902A (ja)
EP (1) EP0750514B1 (ja)
JP (2) JP4004062B2 (ja)
KR (1) KR100352583B1 (ja)
CN (1) CN1089007C (ja)
AT (1) ATE198711T1 (ja)
AU (1) AU700751B2 (ja)
BR (1) BR9507067A (ja)
CA (1) CA2184269A1 (ja)
DE (1) DE69519924T2 (ja)
DK (1) DK0750514T3 (ja)
ES (1) ES2155519T3 (ja)
FI (1) FI114011B (ja)
GR (1) GR3035758T3 (ja)
HK (1) HK1014493A1 (ja)
IL (1) IL112963A (ja)
NZ (1) NZ282659A (ja)
PT (1) PT750514E (ja)
TW (1) TW418091B (ja)
WO (1) WO1995024927A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080050390A1 (en) * 1994-03-14 2008-02-28 Yehuda Shoenfeld Administration of gamma globulins to treat metastatic melanoma
US20070166313A1 (en) * 1994-03-14 2007-07-19 Yehuda Shoenfeld Administration of gamma globulins to treat cancer
CA2331738A1 (en) 1998-05-07 1999-11-11 Research Corporation Technologies, Inc. Oral administration of immunoglobulins for treating autoimmune hearing loss
TWI248819B (en) * 1999-09-27 2006-02-11 Arp Biomed Ltd Pharmaceutical composition containing IVIG for use in treating lymphoma
WO2001066124A2 (en) * 2000-03-10 2001-09-13 Medinnova Sf Composition for the treatment of heart failure
AT410637B (de) * 2001-06-01 2003-06-25 Igeneon Krebs Immuntherapie Verwendung von polyklonalen immunglobulinen
US20050106136A1 (en) 2002-02-15 2005-05-19 Richard Brunner 7s immunoglobulin for treatment of choroidal neovascularisation
US20080031903A1 (en) * 2006-07-27 2008-02-07 Andrea Gambotto Method of treating ocular infections
US20090053217A1 (en) * 2007-05-07 2009-02-26 Miri Blank Human anti-VEGF polyclonal antibodies and uses thereof
WO2010093606A1 (en) * 2009-02-11 2010-08-19 Martin Heath Bluth Reciprocal serum/plasma exchange for the treatment of cancer
CN114129722B (zh) * 2020-09-04 2024-04-05 中国医学科学院输血研究所 注射用人免疫球蛋白在制备预防或治疗辐照损伤的药物中的用途
CN114392351B (zh) * 2021-07-13 2024-04-05 中国医学科学院放射医学研究所 毛螺菌科细菌与注射用人免疫球蛋白的联合用药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699783A (en) * 1983-03-11 1987-10-13 Terman David S Products and methods for treatment of cancer
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
US4699784A (en) * 1986-02-25 1987-10-13 Center For Molecular Medicine & Immunology Tumoricidal methotrexate-antibody conjugate
TWI248819B (en) * 1999-09-27 2006-02-11 Arp Biomed Ltd Pharmaceutical composition containing IVIG for use in treating lymphoma

Also Published As

Publication number Publication date
EP0750514B1 (en) 2001-01-17
KR100352583B1 (ko) 2002-12-26
JP4004062B2 (ja) 2007-11-07
CN1089007C (zh) 2002-08-14
IL112963A0 (en) 1995-06-29
AU1984895A (en) 1995-10-03
NZ282659A (en) 1998-06-26
DE69519924T2 (de) 2001-08-23
PT750514E (pt) 2001-06-29
US5562902A (en) 1996-10-08
FI963598A (fi) 1996-09-12
US5965130A (en) 1999-10-12
CA2184269A1 (en) 1995-09-21
CN1148343A (zh) 1997-04-23
DK0750514T3 (da) 2001-05-21
BR9507067A (pt) 1997-09-30
EP0750514A1 (en) 1997-01-02
JPH09512791A (ja) 1997-12-22
ES2155519T3 (es) 2001-05-16
IL112963A (en) 2000-02-17
DE69519924D1 (de) 2001-02-22
HK1014493A1 (en) 1999-09-30
AU700751B2 (en) 1999-01-14
WO1995024927A1 (en) 1995-09-21
FI963598A0 (fi) 1996-09-12
JP2007119493A (ja) 2007-05-17
GR3035758T3 (en) 2001-07-31
TW418091B (en) 2001-01-11
ATE198711T1 (de) 2001-02-15

Similar Documents

Publication Publication Date Title
JP2007119493A (ja) γグロブリンの投与によるガン性疾患を処置するための免疫療法
Folli et al. Tumor‐necrosis factor can enhance radio‐antibody uptake in human colon carcinoma xenografts by increasing vascular permeability
JPS60502104A (ja) α―インターフェロンに対する抗体と複合されたα―インターフェロン治療製剤
O'Donnell et al. Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium‐DOTA‐peptide‐ChL6
WO1992007466A1 (en) Synergistic therapy with combinations of anti-tumor antibodies and biologically active agents
TWI818120B (zh) 藉由免疫檢查點阻礙藥與ｆｏｌｆｉｒｉｎｏｘ療法之併用的癌症治療
TW202200191A (zh) 包含含有ｉｌ－２蛋白與ｃｄ８０蛋白之融合蛋白及抗癌藥物的用於治療癌症的藥學組成物
EP1220687B1 (en) Administration of gamma globulins to treat lymphoma
US20080050390A1 (en) Administration of gamma globulins to treat metastatic melanoma
CA1340898C (en) Monoclonal antibodies against lymphoma-associated antigens, hybrid cell lines producing these antibodies, and use therefore
JPH07500565A (ja) 免疫抑制ムチンを生成する腺がんの能動的特異免疫療法
NO321038B1 (no) Immunoterapeutisk behandlingsmetode for kreftsykdommer ved tilforsel av gammaglobuliner
CN110151987B (zh) 对称IgG及其组合物在制备治疗及预防肿瘤的药物中的用途
WO2024140833A1 (zh) 药物组合及其应用
WO2023061472A1 (zh) 抗her2抗体药物偶联物和酪氨酸激酶抑制剂联合在制备治疗肿瘤的药物中的用途
US20070166313A1 (en) Administration of gamma globulins to treat cancer
AU650080B2 (en) Synergistic therapy with combinations of anti-tumor antibodies and biologically active agents
Yu et al. Immunotherapy of xenografted human bladder cancer in nude mice using monoclonal antibody
CN115845051A (zh) 一种药物组合物和药物制剂及其在治疗肝癌中的应用
JP2544146B2 (ja) 上咽頭癌治療剤
JPH01197442A (ja) 抗腫瘍剤
WO2000020022A1 (en) Methods for the treatment of cancer using cytokines in combination with low level doses of chemotherapy and/or radiotherapy
WO1996040176A1 (en) Therapeutic uses of monoclonal antibody ta99 in combination with interleukin-2 and/or lymphokine activated killer cells
KR20040091623A (ko) 암 치료

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: ARP BIOMED LTD.

MM Patent lapsed